Novartis AG EBIT 2010-2024 | NVS

Novartis AG EBIT for the quarter ending September 30, 2024 was $3.627B, a 105.85% increase year-over-year.

  • Novartis AG 2023 EBIT was 9.769B, a 22.94% increase from 2022.
  • Novartis AG 2022 EBIT was 7.946B, a 32.02% decline from 2021.
  • Novartis AG 2021 EBIT was 11.689B, a 15.14% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Novartis AG EBIT 2010-2024 | NVS

  • Novartis AG 2023 EBIT was 9.769B, a 22.94% increase from 2022.
  • Novartis AG 2022 EBIT was 7.946B, a 32.02% decline from 2021.
  • Novartis AG 2021 EBIT was 11.689B, a 15.14% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B